摘要:
The present invention encompasses compounds of general formula (1) wherein R1 to R4R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
摘要翻译:本发明包括通式(1)的化合物,其中R 1至R 4 R 3如权利要求1中所定义,其适用于治疗以细胞增殖过度或异常为特征的疾病,以及其用于制备具有上述药物的药物的用途, 上述属性。
摘要:
A method is proposed for determining clinical study compliance. The method includes obtaining criteria for the clinical study and accessing stored clinical data relating to the clinical study. Thereafter, the criteria and clinical data are correlated to determine a measure of compliance with the criteria of the clinical study.
摘要:
The present invention encompasses compounds of general Formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
摘要:
The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
摘要:
The present invention encompasses compounds of general formula (1) whereinR1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
摘要:
The present invention encompasses compounds of general formula (1) wherein R1 to R4, m and n are defined as in the specification, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
摘要:
A method is disclosed for carrying out quality control of medical data records collected from different but comparable patient collectives within the bounds of a medical plan. In the method, for each data record, a quality control parameter assigned thereto is determined in the same manner. Further, the quality control parameters are evaluated using comparison criteria.
摘要:
A method, apparatus and automated terminal are proposed for recruiting patients for at least one clinical study. The method includes screening for suitable clinical study patients in at least one public place, including obtaining information regarding potential patients for entry into a computer device. The method further includes determining, from information entered into the computer device, whether or not the potential patients qualify for at least one clinical study.
摘要:
An electromagnetic relay having a coil core which carries a coil. The coil is connected to one end to the short limb of an L-shaped magnet yoke, on a long limb of the L-shaped magnet, a hinged armature is supported in a manner which allows the armature to pivot about a pivot axis on the long limb of the magnet. In order to achieve a precisely defined switching behavior which is concurrent for the relays of a series, the length of the coil core is produced by means of upsetting as a function of the height of the pivot axis above a base area of the magnet yoke on which the coil core is secured, with the result that the position of the hinged armature with respect to a pole face of the coil core is precisely defined.
摘要:
An apparatus for measuring weak, location-dependent and time-dependent magnetic fields emitted from a source situated in an examination subject includes a sensor arrangement having at least ten gradiometers of the first order, each gradiometer being inductively coupled to a DC-SQUID. The sensor arrangement and the examination subject are disposed in a room which shields the examination subject and the sensor arrangement from magnetic fields. The room has a shielding factor of at least 10 for magnetic alternating fields having a frequency of 0.5 Hz, the shielding factor increasing with increasing frequency. A method for operating the apparatus is also disclosed.